Shift Bioscience
Shift Bioscience is a biotechnology company focused on cell rejuvenation therapeutics for age-driven diseases. They leverage proprietary datasets, AI-powered virtual cells, and cell aging clocks to identify novel targets, such as SB000, a single-gene target that reverses cellular aging across multiple cell types without safety concerns like tumorigenesis associated with Yamanaka factors. Their approach aims to develop therapies that can increase lifespan and address a significant market opportunity in age-related diseases.
Shift Bioscience
Shift Bioscience is a biotechnology company focused on cell rejuvenation therapeutics for age-driven diseases. They leverage proprietary datasets, AI-powered virtual cells, and cell aging clocks to identify novel targets, such as SB000, a single-gene target that reverses cellular aging across multiple cell types without safety concerns like tumorigenesis associated with Yamanaka factors. Their approach aims to develop therapies that can increase lifespan and address a significant market opportunity in age-related diseases.